Transthera Sciences (nanjing), Inc.
Clinical trials sponsored by Transthera Sciences (nanjing), Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill targets bile duct cancer that resists standard treatments Results expected Dec 2026 (estimated)
- New combo therapy shows promise for Hard-to-Treat breast cancer Results expected Jun 2027 (estimated)